tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FDMT Stock Latest News

Promising Outlook for 4D Molecular Therapeutics: Buy Rating Backed by Strategic Partnerships and Strong Financial Position
RatingsPromising Outlook for 4D Molecular Therapeutics: Buy Rating Backed by Strategic Partnerships and Strong Financial Position
2d ago
FDMT
4D Molecular price target raised to $32 from $26 at RBC Capital
PremiumThe Fly
4D Molecular price target raised to $32 from $26 at RBC Capital
3d ago
FDMT
4D Molecular price target lowered to $33 from $38 at Barclays
PremiumThe Fly
4D Molecular price target lowered to $33 from $38 at Barclays
3d ago
FDMT
4D Molecular Therapeutics Reports Strategic Gains in Q3 2025
PremiumCompany Announcements
4D Molecular Therapeutics Reports Strategic Gains in Q3 2025
3d ago
FDMT
4D Molecular sees cash runway into 2H28
PremiumThe Fly
4D Molecular sees cash runway into 2H28
4d ago
FDMT
4D Molecular reports Q3 EPS ($1.01), consensus (98c)
PremiumThe Fly4D Molecular reports Q3 EPS ($1.01), consensus (98c)
4d ago
FDMT
4D Molecular Therapeutics Closes $93.3 Million Stock Offering
Premium
Company Announcements
4D Molecular Therapeutics Closes $93.3 Million Stock Offering
7d ago
8K
FDMT
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Long-term Efficacy, Safety, and Financial Strength Justify Buy Rating
Premium
Ratings
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Long-term Efficacy, Safety, and Financial Strength Justify Buy Rating
7d ago
FDMT
4D Molecular upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe Fly
4D Molecular upgraded to Equal Weight from Underweight at Morgan Stanley
8d ago
FDMT
4D Molecular’s 4D-150 shows efficacy in Phase 1/2 wet AMD trial
PremiumThe Fly
4D Molecular’s 4D-150 shows efficacy in Phase 1/2 wet AMD trial
8d ago
FDMT
4D Molecular 8.386M share Spot Secondary priced at $10.51
PremiumThe Fly
4D Molecular 8.386M share Spot Secondary priced at $10.51
8d ago
FDMT
4D Molecular Therapeutics Reports Positive Interim Trial Results
PremiumCompany Announcements
4D Molecular Therapeutics Reports Positive Interim Trial Results
8d ago
8K
FDMT
4D Molecular Therapeutics Partners with Otsuka for APAC Market
PremiumCompany Announcements4D Molecular Therapeutics Partners with Otsuka for APAC Market
14d ago
8K
FDMT
4D Molecular announces 4D-150 license agreement with Otsuka Pharmaceutical
Premium
The Fly
4D Molecular announces 4D-150 license agreement with Otsuka Pharmaceutical
14d ago
FDMT
4D Molecular Therapeutics Advances in Macular Degeneration Treatment: A Phase 3 Study Update
Premium
Company Announcements
4D Molecular Therapeutics Advances in Macular Degeneration Treatment: A Phase 3 Study Update
18d ago
FDMT
4D Molecular Therapeutics Advances Gene Therapy for Wet AMD
PremiumCompany Announcements
4D Molecular Therapeutics Advances Gene Therapy for Wet AMD
18d ago
FDMT
4D Molecular Therapeutics Advances Gene Therapy Trial for Cystic Fibrosis
PremiumCompany Announcements
4D Molecular Therapeutics Advances Gene Therapy Trial for Cystic Fibrosis
18d ago
FDMT
4D Molecular Therapeutics Advances Phase 3 Trial for Vision Loss Treatment
PremiumCompany Announcements
4D Molecular Therapeutics Advances Phase 3 Trial for Vision Loss Treatment
18d ago
FDMT
4D Molecular Therapeutics Advances Gene Therapy Trial for Fabry Disease
PremiumCompany Announcements
4D Molecular Therapeutics Advances Gene Therapy Trial for Fabry Disease
18d ago
FDMT
4D Molecular announces CF Foundation will provide $11M for 4D-710
PremiumThe Fly4D Molecular announces CF Foundation will provide $11M for 4D-710
1M ago
FDMT
4D Molecular Therapeutics Appoints New Financial Officer
Premium
Company Announcements
4D Molecular Therapeutics Appoints New Financial Officer
1M ago
8K
FDMT
4D Molecular appoints Clark as CMO, Zhu as SVP, CMO Kim to step down
Premium
The Fly
4D Molecular appoints Clark as CMO, Zhu as SVP, CMO Kim to step down
2M ago
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >